Monday 30 November 2020

Global Healthcare Contract Manufacturing Market- Demand, Analysis and Forecast

Global Healthcare Contract Manufacturing Market Research Report: Information by Type (Sterile and Non-Sterile), Service Type (Pharmaceutical Contract Manufacturing and Medical Device Contract Manufacturing), Industry (Pharmaceutical Industry, Medical Device Industry and Biopharmaceutical Industry) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) - Forecast till 2023

Overview:

The healthcare contract manufacturing market is benefiting much from the growing demand for medicine supplies which is facing a severe crisis from the pending expiration of a lot of generic drugs. The market relies heavily on the outsourcing of the manufacturing process of drugs to contract manufacturers. From drug development to drug manufacturing, a comprehensive platform this healthcare contract manufacturing sector provides. The from drug development to drug manufacturing market is expecting a growth by 9.86% during the forecast period (2017-2023), claims Market Research Future (MRFR). The report ensures a detailed analysis of the segments and driving factors that can assist the market in growth over the review period.

Among the factors, patent expiration of several drugs can be deemed as one of the chief influencers that can foster the mark

et growth during the forecast period. Emerging economies are demanding for greater percolation as the population boom in those countries have created scope for substantial market expansion. Drug manufacturers are also looking for significant contribution from these companies as number of drugs in the pipeline is getting piled up. Factors such as these are bound to boost the global from drug development to drug manufacturing market.

On the flip side, controlling third parties is quite complex which many manufacturers prefer to avoid. At the same time, clinical trials are becoming more exhaustive and tangled which can deter the healthcare contract manufacturing market from having the expected growth rate over the review period.

Segmentation:

The global healthcare contract manufacturing market can be segmented by type, service type, and industry.

Based on the type, the healthcare contract manufacturing market can be segmented into sterile and non-sterile.

On the basis of the service type, the healthcare contract manufacturing market includes pharmaceutical contract manufacturing services, medical device contract manufacturing services.

Industry-wise segmentation of the healthcare contract manufacturing market includes pharmaceutical, medical device, and biopharmaceutical.

Regional Analysis:

Region-specific analysis of the global healthcare contract manufacturing market includes the Americas, Asia Pacific (APAC), Europe, and the Middle East & Africa (MEA).

The Americas is in charge of the global healthcare contract manufacturing market. With rising investment in healthcare, the focus is mainly on improving healthcare infrastructure and upgrading research institutions for better technology and others. Subsequently, manufacturers are now relying more on the advanced instruments they have put in use in their factories and manufacturing capabilities.

Europe assumes the second position in the market and the credit goes to the increased expenditure initiated by the regional governments. The reports published by the Organization for Economic Co-operation and Development (OECD) discloses that Germany spent USD 321 billion in 2014 in the healthcare sector which is a significant marker of the progress the regional market is making at present.

The APAC is the fastest growing market as major regional economies such as China and India are considerably investing to better their healthcare facilities to lure in patients from all over the world as a part of their medical tourism planning.

Competitive Analysis:

Some of the key players in this healthcare contract manufacturing market are Aesica Pharmaceuticals, Boehringer Ingelheim, AbbVie, Grifols International, S.A, Evonik Industries, Lonza Ag, Catalent, Benchmark Electronics, Flex Ltd, Forefront Medical Technologies, Hamilton Company, Sanmina Corporation, Teva Pharmaceutical Industries, Patheon, Mylan, Vetter Pharma International, and others.

In August 2018, Catalent completed their move to acquire Juniper. This would give the former a new and robust European base to function. Catalent, as the parent company of Juniper, would ensure the supply of Crinone marketed by Merck KGaA.

In January 2018, Intermountain Healthcare declared their plan to create a non-profit generic drug company as a direct manufacturer or contract manufacturer in collaboration with Ascension, SSM Health, and Trinity Health.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com

NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

Latest Research On Diagnostic imaging Market Key Manufactures Shares, Analysis and Forecasts Till 2023

Market Highlights

The Global diagnostic imaging market size is projected to grow at a CAGR of 8.2% over the forecast period. In recent years, diagnostic imaging services improved their efficiency and accuracy for the of various acute and chronic diseases including cardiovascular diseases and cancer. The increasing prevalence of geriatric population and subsequent growth in the incidence of cardiac, and neurological diseases including cancer, growing government funding’s for development of medical diagnostics field, and the on-going technological advancements in imaging services are some factors that are anticipated to drive the market growth during the assessment period. Additionally, increasing demand for diagnostic imaging devices and development expenditure by the government as well as private sector is likely to contribute to the market growth. As per the data by the Office for National Statistics, in 2016, the gross domestic expenditure on research and development (R&D) was Euro 33.1 billion (USD 35.2 billion) in the UK. However, high cost of diagnostic imaging devices and unfavorable reimbursement policies may hamper the market growth during the assessment period.

Get Latest Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/7186

Segmentation

The Global diagnostic imaging services market has been segmented into procedure, application, and service provider.

By procedure, the market has been segmented into X-ray, Computed Tomography, Ultrasound, MRI (Magnetic Resonance Imaging), Nuclear Imaging, Radiography and others. The procedure segment is estimated to hold major market share in the global diagnostic imaging services market due to the rising R&D activities in the medical diagnostics field.

On the basis of application, the global diagnostic imaging services market has been segmented into Neurology, Cardiology, Oncology, Musculoskeletal and others.

The Global diagnostic imaging services market, by service provider, has been segmented into Clinics & Hospitals, Diagnostic centers, Research laboratories and others.

Key Players

Some of the prominent players in the global diagnostic imaging services market are Center for Diagnostic Imaging (CDI), Medquest Associates Inc./Novant Health, Simonmed/Dignity Health, Touchstone Imaging, Alliance Medical, Medica Group, Sonic Healthcare, Global Diagnostics, Consensys Imaging Service, Inc., Progressive Radiology, Concord Medical Services Holdings Limited, Alliance Healthcare Services, InHealth Group and others.

Browse Complete Report @ https://www.marketresearchfuture.com/reports/diagnostic-imaging-services-market-7186

Regional Analysis

On regional basis, the Americas is anticipated to dominate the global diagnostic imaging services market owing to the growing clinical R&D budgets by both government as well as public and private organizations in diagnostic imaging modalities and increasing adoption of advanced technologies in the region. Additionally, rising prevalence of geriatric population along with various chronic diseases is contributing the growth of this market. According to a report by Population Reference Bureau, the number of older population (aged 65 and above) will rise to nearly 24% from 15% by 2060. Europe is expected to hold the second largest position in the global diagnostic imaging services market owing to the presence of strong academic & research base and availability of funding for research in the European countries. Moreover, rising healthcare expenditure and awareness among people for detection of diseases is boosting the market in this region. The Asia-Pacific region is anticipated to be fastest growing region is due to rising demand for imaging devices, good quality healthcare infrastructure and incidence of major key players for growth and development in this region. The Middle East & Africa has the least share of the global diagnostic imaging services market. Moreover, the major market share of the region is expected to be held by the Middle East region owing to the increasing government initiatives for the healthcare sector.

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com

News 2020: Hair transplant Market Size, Trends and Global Demand by 2023

Hair transplant surgery defined as a medical procedure where small pieces of hair-bearing scalp grafts are removed from a donor site and then relocated them to a bald or thinning area. A new report on the global hair transplant market, published by Market Research Future (MRFR), anticipates that this market can see advancement at 24% CAGR during the forecast period (2017-2023). In terms of money value, the market is to be worth USD 23,881.9 Mn by the end of the forecast period.

You can also read here!! https://www.medgadget.com/2020/10/hair-transplant-market-growth-and-demand-2020-industry-size-share-statistics-business-development-revenue-growth-insight-leading-players-competitive-analysis-and-emerging-technologies.html

The chief market driving factors for the global hair transplant market growth are the increasing number of surgical procedures and rising consumption of high doses of drugs. Other global hair transplant market driving factors that can progress the global hair transplant market growth include changing lifestyle of individuals, increasing awareness among people about their looks, increasing trend of looks being given more importance over other qualities, increasing research & development (R&D) to prevent hair fall, and technological advances in hair transplant procedures. However, the availability of alternative treatments and the high cost of hair transplant procedures can restrain the global hair transplant market growth.

Market Segmentation

The global hair transplant market segmentation encompasses end-user, surgical method, and surgery type. MRFR’s research on the market highlights many facets of the market in-depth.

Taking end-users into consideration the report segments the market includes dermatologic clinics, hospitals, trichology clinics, and others. By surgery type, the market segmented into eyebrow transplant, frontal hairline lowering or reconstruction, head hair transplant, and others.

Based on the surgical method, the market has been segmented into follicular unit extraction (FUE), follicular unit transplantation (FUT), and others. The follicular unit extraction (FUE) segment has been sub-segmented into automated FUE hair transplantation, follicular isolation technique, and robotic hair transplantation.

Regional Segmentation

A geographical outlining of the global hair transplant market covers the Americas (North America & Latin America), APAC (Asia Pacific), Europe, and the Middle East & Africa (MEA).

In the Americas, the market is strong due to the changing lifestyle of people, extensive use of cosmetics, growing demand for the restoration of hair, and increasing emphasis on skincare. The presence of major market players, availability of advanced medical facilities, and technological advancement make North America a bigger market compared to Latin America. In North America, many people, especially women, go through hair transplant procedure due to hormonal changes, increased psychological stress, poor dietary habits, and reduced nutritional levels as the age progresses. Many important market players are from the USA. Second highest market revenue in this region comes from Canada.

The Asia Pacific region is the second-largest regional market due to deterioration of physical as well as mental health among youth, increasing incidences of stress as well as workload, lifestyle disorders, and rising prevalence of skin disease. The depression among youngsters causes hair loss due to increasing social influence, peer pressure, and psychological stress. The countries that can be crucial markets in this region are China, India, Japan, and South Korea. An examination of the remaining countries in the Asia Pacific region featured in this report sums up the additional market revenue from some other countries.

In Europe, the market is growing due to lower hair transplant treatment costs, mounting demand for technological advancement in cosmetics as well as skincare, and unhealthy eating habits of adults as well as teenagers. The growing urbanization in France, Germany, and the UK is also boosting the market growth. Other countries that can become important markets during the forecast period are Italy and Spain. Research on the remaining countries in Western Europe featured in this report estimate the strong addition to market revenue from various other countries in this region, with some sizable market revenue from Eastern Europe.

The MEA is expected to emerge as a sound regional market in the near future due to developing healthcare infrastructure, growing awareness about hair transplant procedure, and increasing spending on healthcare.

Key Players

Big players in the global hair transplant market are Bernstein Medical (USA), Bosley (USA), Cole Instruments Inc. (USA), Ethics hair Instruments (India), Medicamat (France), and Restoration Robotics Inc. (USA).

Latest Industry News

Brentwood-based Revive Hair and Skin Clinic has partnered with Watford FC Regional Partner Programme to reach thousands of football fans. The specialty of Revive Hair and Skin Clinic lies in hair transplants and skin treatments. 18 SEP 2019

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

Regional Trends on Smart Insulin Pens Market Size by Top Companies, Share, REport and Demand by 2027

Global Smart Insulin Pens Market: Information By Product Type (Smart Pen and Connecting Device), End-User (Hospital/Retail pharmacies and Online) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) - Forecast till 2027

Smart insulin pens are devices used to deliver the accurate dose of insulin to diabetics at the appropriate time. They have gained traction among diabetics due to its simplistic nature and easy to handle mechanism compared to traditional syringes. The global smart insulin pens market report by Market Research Future (MRFR) contains the pertinent drivers and challenges faced by manufacturers during the period of 2020 to 2027.

Smart Insulin Pens Market Overview

Global Smart Insulin Pens Market was valued at USD 72.97 Million in 2019 and is expected to register a CAGR of 10.77% during the forecast period of 2020 to 2027. Furthermore, the use of these devices for the management of diabetes by the general populace in developing countries can bode well for the market during the forecast period. Awareness of advanced drug delivery methods, need for modern treatments, and the alarming cases of diabetes can bolster the global market demand till 2027.

Get Free Sample Copy With Covid19 Impact@https://www.marketresearchfuture.com/sample_request/6789

The surge in the adoption rate of glucose monitoring devices, awareness of these devices, and integration of glucose measurement devices are other drivers of the market. According to the World Health Organization (WHO), diabetes was accountable for 1.2 million deaths in 2012. This can spark the demand for smart insulin pens for proper management of diabetes. Co-pay assistance and medical reimbursement policies covering the purveying of these devices can ensure the continuous sales.

Unfavorable reimbursement policies, risks associated with insulin pens, and increasing costs of insulin pens are challenges faced by the market.

Smart Insulin Pens Market Segmentation

The global smart insulin pens market has been segmented on the basis of product type, usability, and distribution channel.

On the basis of product type, the market has been segmented into first-generation pens and second-generation pens. The second-generation pens segment has been further divided into Bluetooth-enabled and USB connected.

By usability, the segment has been divided into disposable pens and reusable pens. Reusable insulin pens segment is likely to be the fastest growing segment during the forecast period.

The market, by distribution channel, has been segmented into retail pharmacies, diabetes clinics, online medical stores, and hospital pharmacies.

Smart Insulin Pens Market Regional Analysis

The Middle East & Africa (MEA), Americas, Asia Pacific (APAC), and Europe are regions discussed in the global smart insulin pens market report.

The Americas can be the leading region of the global market till 2023 due to favorable policies by regulatory authorities, adoption of advanced technology, and rising prevalence of diabetes among the general populace. The approval of novel injectable devices by regulatory agencies can drive the global smart insulin pens market growth.

The Europe smart insulin pens market is driven by adoption of advanced drug delivery devices, rising cases of diabetics, and presence of major players. According to the World Diabetes Foundation, more than 59 million have been diagnosed with diabetes, with the number purported to touch 71.1 million by 2040.

Government policies for assisting diabetics and rise in disposable income levels of patients are main drivers of the smart insulin pens market in APAC. Large cases of diabetes recorded in Southeast Asia can drive the regional market growth. As per the International Diabetes Federation, the number of diabetics in the region can touch 156 million by 2045.

Competition Outlook

InjexUK, Lilly USA, LLC, Digital Medics Pty Ltd., Companion Medical, Sanofi-Aventis US LLC, Diamesco Co., Ltd., Smith’s Medical, NIPRO Medical Corporation, Novo Nordisk A/S, Biocorp, Emperra GmbH E-Health Technologies, and others are notable players of the global smart insulin pens market. Manufacturers are launching new iterations of smart insulin pens for recording the proper dosage amounts and reminders of taking insulin shots at the appropriate time. For instance, the InPen by Companion Medical can capture mealtime data and shares it on the respective medical mobile application.

Industry News

Recently, Medtronic and Novo Nordisk have decided to pool in their offerings for sharing the data acquired by their smart insulin pens on a common diabetes management platform.

List of Table:

TABLE 1 LIST OF ASSUMPTIONS 13

TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 16

TABLE 3 NUMBER OF ADULTS (20–79 YEARS) WITH DIABETES WORLDWIDE (MILLION) 22

TABLE 4 GLOBAL SMART INSULIN PENS MARKET, BY PRODUCT TYPE, 2016–2027 (USD MILLION) 31

TABLE 5 GLOBAL SMART INSULIN PENS MARKET, FOR SMART PEN, BY REGION, 2016–2027 (USD MILLION) 32

TABLE 6 GLOBAL SMART INSULIN PENS MARKET, FOR CONNECTING DEVICE, BY REGION, 2016–2027 (USD MILLION) 33

TABLE 7 GLOBAL SMART INSULIN PENS MARKET, BY DISTRIBUTION CHANNEL, 2016–2027 (USD MILLION) 34

TABLE 8 GLOBAL SMART INSULIN PENS MARKET, FOR HOSPITAL/RETAIL PHARMACIES, BY REGION, 2016–2027 (USD MILLION) 35

TABLE 9 GLOBAL SMART INSULIN PENS MARKET, FOR ONLINE, BY REGION,2016–2027 (USD MILLION) 36

TABLE 10 GLOBAL SMART INSULIN PENS MARKET, BY REGION 2016–2027 (USD MILLION) 37

Read More About report@

https://www.marketresearchfuture.com/reports/smart-insulin-pens-market-6789

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

Vocal Biomarkers Market Technology Trends, Demand, Key Trends and Forecast

Global Vocal Biomarkers Market to Exhibit a Healthy Growth in 2019, Asserts MRFR

Global vocal biomarkers market to witness a healthy growth in forthcoming years projects Market Research Future (MRFR) in its latest report. Increased prevalence of neurological, psychological and other disorders that affects speech is fuelling the demand for vocal biomarkers. Health issues such as Disruptive Behavior Disorders, Alzheimer's disease, Parkinson's disease (PD), Huntington's disease, attention deficit, depression, and respiratory and cardiovascular disorders are associated with speech impairment. There are cases when traumatic brain injury (TBI) was identified as cause of speech loss. A WHO report revealed that in 2016, close to 350 million people were suffering from depression. In the same, The Parkinson’s disease Foundation reported that around 10 million people were suffering Parkinson’s.

Request Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/3933

Biomarkers are also used for detecting speech related issues in soldiers. Hence, the defence sector has potential for vocal biomarker application. For instance, the U.S Army joined forces with MIT researcher to collaboratively work on developing advanced biomarker technology that can cater to traumatic brain injury. America Heart Association in partnership with Mayo Clinic and Beyond Verbal has created unique artificial intelligence (AI) algorithms using cutting-edge machine-learning tools to perceive voice patterns uncatchable by human ear for initial identification of coronary heart disorders.

Rapid mobile technology penetration and boom of the IT sector is creating supporting the market growth. Moreover, the arrival of advanced wearable technologies along with improving the network quality and bandwidth is partly influencing the market. Market players are actively focusing on product innovation in order to gain a competitive edge. Many companies are also entering into collaboration and partnerships to boost their R&D capacity.

Segmental Overview

The segmental analysis of the global vocal biomarker market is based on indication, type and end users.

On the basis of indication, the market has been segmented into neurological disorders, psychiatric disorders, respiratory disorders, traumatic brain injury (TBI), cardiovascular disorder. The neurological disorders segment is further sub-segmented into Alzheimer’s disease, Parkinson’s disease, huntington’s disease, and others. The psychiatric disorders segment is further sub-segmented into disruptive behaviour disorders, attention deficit, depression and others. On the basis of type, the market has been segmented into pitch, amplitude, vocal rise or fall time, voice tremor, frequency, error rate, phonation time, and others. On the basis of end users, the market has been segmented into academic and research, hospitals and clinics and others.

Global Vocal Biomarkers Market: Regional Segmentation

The market has been covered across key regions, which include North America, Asia Pacific (APAC), Europe, the Middle East & Africa (MEA) and Latin America. North America is expected to remain highly profitable market for vocal biomarkers during the forecast period. In North America, the U.S. makes a significant contribution to the vocal biomarker market. This is primarily owing to the presence of effective reimbursement scenario and high healthcare spending. Moreover, faster acceptance of the advanced technologies in the U.S. makes it a potential market. Following on the heels of North America, Europe represents the second largest market for vocal biomarker. High level of awareness and growing healthcare expenditure are two of the key factors driving the market in Europe. Asia-Pacific ranks third in the pecking order in terms revenue. The market in APAC is touted to witness a strong growth over the next several years. India and China are major contributors to the market in the region.

Competitive Landscape

MRFR in its report has mentioned some of leading companies operating in the global vocal biomarker market, which include Sonde Health, IBM Corporation, Beyond Verbal, Cogito Corporation, and Audio Profiling.

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com

Report: Cystic Fibrosis (CF) Therapeutics Market 2020 | Size| Trends | Global Report | News

The global market consist of players such as AbbVie, Allergan plc, Chiesi Farmaceutici S.p.A., F. Hoffmann-La Roche AG, Gilead Sciences, Inc., Novartis AG, Pharmaxis Ltd, PTC Therapeutics, and Vertex Pharmaceuticals Incorporated are some of the prominent players at the forefront of competition in the global cystic fibrosis market and are profiled in MRFR Analysis report.

Cystic Fibrosis Market is expected to register a CAGR of 13.5% and is anticipated to reach USD 12,943.1 million by 2025

Global Cystic Fibrosis Market - Overview:

According to a recent study report published by the Market Research Future analysts, the global cystic fibrosis (CF) therapeutics market is growing at a double digit CAGR. The major growth in the cystic fibrosis market was observed with the introduction of Kalydeco drug by Vertex pharmaceutical in 2012. There has been constant development of new drugs and therapies for treating cystic fibrosis. Cystic fibrosis foundation (CFF) has always been in support of the companies involved in the research and development of the cystic fibrosis drugs. The financial support from CFF is influential in the growth of the cystic fibrosis market worldwide.

That being said, there are few hurdles as well in growth of this market. Currently there are approximately 1900 identified CFTR mutations that are responsible for the development of the disease condition. Many are yet to be identified. At present, treatments are available for nearly half the mutations. CF being the rare disease, and due to the limited information available, the extensive research is required. The research and development cost for the cystic fibrosis is very high leading to the massive prices of the end products. High cost of the drugs and treatments is one of the factors that hinder the growth of the cystic fibrosis market.

Global Cystic Fibrosis Market - Regional Analysis;

Cystic fibrosis can occur in both genders as well as in all ethnic groups and races. However the incidences of cystic fibrosis varies across the globe. Cystic fibrosis is more common among the Caucasians. Hence the disease is more prevalent in North America, Europe, and Australia. However cystic fibrosis can also affect Latinos, American Indians, African, and Middle Eastern population.

North America is one of the majorly affected region by the deadly disease cystic fibrosis. The United States is among the countries with highest incidence rates of cystic fibrosis. According to cystic fibrosis foundation, more than 30,000 patients are living with cystic fibrosis in the United States. Nearly, 1000 new cystic fibrosis cases are diagnosed each year. According to CFF’s national patient registry, the median age of the person with cystic fibrosis is currently 33.4 years. The average life expectancy of the CF patients has increased significantly as compared to the patients 30 years back.

European region is also largely affected by cystic fibrosis. According to European Cystic Fibrosis Society (ECFS), considering the 26 major countries in Europe, more than 35,500 people were suffering from cystic fibrosis in 2014. Among the CF patients in Europe, 51.8% were adults with age 18 years or more and 48.2% were less than 18 years old. Countries like United Kingdom, Ireland, Romania, and Bulgaria have the high birth prevalence of CF.

The prevalence of cystic fibrosis is seen to be very low in the Asian region. There is limited information available about CF in Asia, it is likely that the disease is highly underdiagnosed in this region including the Indian subcontinent. It is due to medical community’s lack of knowledge about CF and poor access to the medical and healthcare facilities for cystic fibrosis patients.

The incidence of cystic fibrosis in Middle East varies according to the ethnic background. However, the CF prevalence in Middle East is low as compared to the North American and European region. There are no accurate CF prevalence number for the Northern African countries, but it is expected to be low due to the racial factor and no European genetic mixture.

Global Cystic Fibrosis Market - Competitive Analysis:

The global market for cystic fibrosis is dominated by American pharmaceutical company Vertex Pharmaceuticals Incorporated. With two FDA approved CFTR modulator drugs Kalydeco & Orkambi, Vertex Pharmaceuticals secured a top spot with the market share of 46% in the global cystic fibrosis market. Kalydeco and Orkambi are the drugs that affect the disease at a genetic level where as all the other drugs from different companies deal with the disease symptoms and associated problems. Currently there is no competition for the Kalydeco and Orkambi. Moreover the Vertex is on the verge of developing their next and better drug “triple combo” which is expected to cover 90% of the total identified CFTR mutations. This development is the strong reason for Vertex pharmaceutical to be on top of the table in the near future as well.

Apart from the Vertex, there are some companies which are manufacturing different drugs for the treatment for the cystic fibrosis. These companies have drug products such as Roche- Pulmozyme, Abbvie- Creon, Gilead- Cayston, Novartis- TOBI Podhaler, Allergan- Zenpep, Chiesi- Pertzye, and few others. As these products help patients in managing the cystic fibrosis symptoms and are consumed daily, these companies have fair amount of share in the market. Additionally, there are other companies which such as Pharmaxis, PTC therapeutics, Janssen Pharmaceuticals, Inc which are involved in the development of the treatments for the symptoms of cystic fibrosis.

Access Complete Report @ https://www.marketresearchfuture.com/reports/cystic-fibrosis-market-1825

2022 Available At Market Research Future

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com

Sunday 29 November 2020

Analysis On Homeopathic Medicine Market -Key Trends and Growth By 2023

Homeopathy Market Driven by Growing Customer Preference to Alternative Medicine

Growing Demand for Safe Medicine to Drive Homeopathy Market

The global homeopathic medicine market is expected to rise to a valuation of more than USD 31.4 billion by 2023, exhibiting a strong 14.60% CAGR over the forecast period, according to the latest research report from Market Research Future (MRFR).

Competitive Analysis:

Leading players in the global homeopathy market include Homeocan Inc., GMP Laboratories, Nelsons & Co. Ltd., Hyland’s, Heel, Weleda, and Boiron Group.

Segmentation:

The global homeopathy market has been segmented on the basis of type, application, source, and end user.

By type, the global market has been segmented into tablets, ointments, biochemics, tincture, dilutions, and others.

Based on application, the global market has been segmented into dermatology, gastroenterology, immunology, neurology, respiratory, analgesic and antipyretic, and others.

Based on source, the global market has been segmented into minerals, animals, plants. The plant segment is likely to dominate the global homeopathy market over the forecast period.

By end user, the global market has been segmented into homeopathic clinics, hospitals, retailer, E-retailer, research laboratories, and others.

Regional Analysis:

The global homeopathy market is expected to be dominated by Europe over the forecast period, according to the MRFR report. The homeopathy market has prospered in Europe, as Europe is the place where it was first invented and most practiced. As a result, Central European countries such as Germany, Austria, and the Czech Republic have longstanding traditions of homeopathic medicine. This is likely to drive the homeopathy market in the region over the forecast period. Increasing demand for homeopathy in the UK is also likely to be a major driver for the homeopathy market in Europe over the forecast period. The UK has faced an increasing demand for homeopathy medications in recent years due to the safe effects of the medicine and the growing preference for alternative medicine in the region. This is likely to remain a major driver for the global homeopathy market over the forecast period.

The Americas is expected to hold the second largest share in the global homeopathy market over the forecast period due to the growing demand for homeopathic medicine in North America. The U.S. and Canada are the major regional markets for homeopathy medicine in the Americas and are likely to retain their leadership in the market over the forecast period due to the increasing demand for alternative medicine in the region. U.S. customers rank as one of the highest ranking practitioners of alternative medicine, with several alternative medicines finding strong growth prospects in the U.S. Homeopathy is likely to benefit from the growing demand for cheaper alternatives to conventional medicine. On the other hand, issues regarding the coverage of homeopathic medicines under healthcare plans are likely to haunt the homeopathy market in North America over the forecast period. Increasing demand from Latin and Central America is also likely to be a key driver for the homeopathy market over the forecast period.

Asia Pacific is also likely to be a major regional market for the global homeopathy market over the forecast period. Due to the strong presence of alternative traditional medicines in the region, the Asia Pacific has always remained more open to alternative medicines than other regions. This has driven the homeopathy market at a steady growth rate in the region and is likely to enable smooth market growth over the forecast period. Growing interest among poorer patients in Southeast Asia is likely to be a major driver for the global homeopathy market over the forecast period. Japan is also likely to remain a key regional market for homeopathy market players in Asia Pacific over the forecast period.

However, the increasing use of homeopathic medicine to sell quack medicine could emerge as a key restraint on the homeopathy market in Asia Pacific over the forecast period. In July 2019, the Maharashtra state of India issued notices to 167 manufacturers and distributors of homeopathic and ayurvedic medicine. Most of the medicine were for sex organ enhancement, along with other ailments and maladies such as diabetes and arthritis. The increasing prevalence of diabetes in Asia Pacific is likely to further drive the homeopathy market in the region over the forecast period.

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com

NEWS: Aromatherapy Market -global Trends, Demand, Size, Share and Forecast

Aromatherapy Market analysis

Aromatherapy is an alternative form of medicine which relies on scented oils and other essential compounds for improving the well-being of individuals. It can be used in conjunction with other complementary treatments of acupuncture or massage for management of chronic diseases or other medical symptoms. The global aromatherapy market report compiled by Market Research Future (MRFR) contains drivers, trends, developments, and challenges new entrants and existing players can face in the period of 2017 to 2023.

Market Overview

As per MRFR, the global Aromatherapy Market Analysis is poised to display a CAGR of 6.18% from 2017 to 2023 (forecast period). It can touch a value of USD 4.3 billion by 2023. Benefits of the treatment after inhalation of the aroma can induce relaxation is likely to bode well for the market. A prime example includes the diffusion of eucalyptus oil can assist in digestion of foods.

Changes in lifestyles of consumers and a large number of people opting for the complementary treatment are other major drivers of the market. Clinical trials advocating the advantages of aromatherapy for the treatment of disorders can influence the market considerably. According to Cancer.gov, 58 patients showed a decrease in depression and anxiety after completion of aromatherapy sessions. Availability of various oils at lifestyle stores and online channels can fuel the global aromatherapy market growth till 2023.

But lack of proper regulations and allergic reaction of the oil to customers are factors which can prevent market growth.

Segmentation

The global aromatherapy market is segmented by product, application, and therapeutic application.

By product, it is segmented into essential oils, carrier oils & blended oils, equipment, and others. Essential oils are further segmented into herbaceous/camphoraceous, green/vegetative, spicy, citrus, floral, and others. Ultrasonic diffuser, heat diffuser, and nebulizer diffuser are other segments subsumed within the equipment segment.

By application, it is segmented into aerial diffusion, inhalation, and tropical.

By therapeutic application, it is segmented into skin and hair care, relaxation and sleep, pain management, and others.

Regional Analysis

Asia Pacific (APAC), North America, Europe, and the Middle East & Africa (MEA) are the regions discussed with respect to the market report.

North America is estimated to be one of the profitable regions for the global aromatherapy market till 2023 due to consumers opting for the treatment in the U.S. The large population and their high expendable income levels are major growth drivers of the region.

Europe is the second-largest region with France and Italy proving to be the revenue generators. Pursuance of healthy lifestyles as well as renewed interest among the people residing in the region are prime factors driving market growth. The inclusion of essential oils by popular cosmetic brands can boost the global aromatherapy market demand.

The APAC region can display a robust CAGR during the forecast period driven by consumer demand in China and India. Rising number of accidents combined with the use of oils for treating burns and scars as natural remedies can bode well for the market. Furthermore, old traditions and rituals in addition to the large number of tourists visiting for experiences can bode well for the region.

Lastly, the MEA region can contribute to the market due to the regions of Saudi Arabia and UAE. Efforts by respective governments for promoting tourism can be a viable factor for the expansion of the global aromatherapy market in the region.

Competition Outlook

Muji, Nu Skin, Tree of Life, Neal's Yard Remedies, NOW Foods, Young Living, Air Aroma, doTERRA, and Zija International are notable industry participants of the global aromatherapy market. Launch of new products and associated stationery are being launched by players for promoting the alternative form of treatment.

Industry News

Aromafloria, the US based producer of bath and body products, has launched aromatherapy based products in its new product line of Cannafloria Essentials. It contains cannabis terpenes which gives the solutions a distinct aroma.

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com

Analysis On Dental Sterilization Market (2018-2023) | Analysis | Size| share| Demand by Top Companies

Dental sterilization is a highly crucial part of maintaining the tools and techniques related to dentistry. As per the latest published report by Market Research Future (MRFR), the global dental sterilization market is expected to grow at a CAGR of 6.90% during the forecast period of 2017 to 2023. The market valuation is expected to jump from USD 1.11 billion back in 2017 to USD 1.5 billion by the end of the forecast period.

A key driver influencing the demand for dental sterilization is the widespread prevalence of dental related diseases or disorders. Dental caries, one of the most common tooth-related issues, is one of the primary reasons behind the loos of tooth and remains a significant concern across developed economies in the world. Consumption of fast food and sugar-rich food items are acting as the main culprits behind incidences of tooth decay and is likely to continue in the coming years as well, thereby driving the growth of the market over the forecast period.

One of the biggest results out of the growing prevalence of dental diseases have been the rising number of dental care facilities. The growth factor associated with the dentistry field is likely to continue in the near future. This, in turn, helps drive the dental sterilization market towards a period of growth.

Market Segmentation

The global dental sterilization market comprises of the following segments: products and end-users.

By product type, the market includes consumables, instruments, and accessories. Among these, the instruments segment is most likely to maintain its dominance over others in terms of market share contribution during the forecast period.

By end-user, the market divides into dental laboratories and hospitals. The hospitals segment is most likely to remain the largest contributor of the two during the forecast period.

Regional Analysis

The geographical segmentation of the global dental sterilization market covers the following regions, Europe, Asia Pacific, North America, and the Rest of the World.

North America leads the chart with the highest market share percentage in the global dental sterilization market. This is primarily due to the widespread prevalence of dental-based diseases in the region and ease of availability concerning the use of advanced dental sterilization equipment. Dental caries is one of the most common requirement in dental hygiene, especially in the US, and affects close to 90% of the school-going children. All these factors are poised to make the North American market maintain its topmost standings over the forecast period.

The Asia Pacific region is considered to be an emerging region in the global landscape, however, it plays a major role in the overall development of the market. Herein, fast-paced urbanization in developing countries like India and China has incepted the adoption of Western-like diet system. This has posed to be an increasing problem for the dental health of consumers residing in the Asia Pacific region. Alongside this, the growing number of dental care centers and clinics across these countries is increasingly likely to drive the demand for the global dental sterilization market in the Asia Pacific region during the forecast period.

Competitive Analysis

The global dental sterilization market comprises of a number of key players, including Matachana Group, Planmeca Group, Danaher, A-Dec, Hu-Friedy, Scican, Tuttnaue, W&H, BMT Medical Technology, Getinge, Midmark, Dentsply Sirona, Nakanishi, Crosstex, and Premier Dental.

March 12th, 2019, Planmeca became the first-ever dental manufacturer to offer a comprehensive suite of IoT solutions for large clinics as well as clinic chains. The unique device of Planmeca makes it easy to access different sets of data and analyze the same.

March 12th, 2019, Planmeca and Navigate Surgical Technologies, aka NST, a recognized provider of real-time surgical navigation services, announced their collaboration in order to launch innovative solutions for dental implant surgeries. The partnership is promises to offer dental implant surgeons to deliver enhanced and clinical patient outcomes. The tech offers more precise and accurate implant placement.

TABLE OF CONTENTS

1 Executive Summary

2 Market Introduction

2.1 Market Definition

2.2 Scope Of The Study

2.3 List Of Assumptions

2.4 Markets Structure

3 Market Research Methodology

3.1 Research Process

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

3.5 Forecast Model

4 Market Dynamics Of Global Dental Sterilization Market

4.1 Introduction

4.2 Drivers

4.3 Restraints

4.4 Opportunities

4.5 Challenges

4.6 Trends/Technology

5 Market Factor Analysis Of Global Dental Sterilization Market

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com

News: Lab-on-a-Chip device market | Growth Factors | Demand| Size | Share and Trends

Market Insights

According to the reports published by Market Research Future, the global lab-on-a-chip device market is projected to exhibit robust growth with registering a CAGR of 10% by the year 2023. The lab-on-a-chip device brings diverse laboratory processes on a minimally sized integrated circuit and thus, eases the sample handling process and delivers results with excellent efficiency.

Latest Free Sample Copy Available @ https://www.marketresearchfuture.com/sample_request/6215

With that, quick sampling with precise results within a short span of time can easily solve problems such as drug wastage as well as drug resistance. By this, it enables the patients to have timely diagnosis and ensures adequate time to start with necessary medical procedures. Therefore, lab-on-a-chip offers optimization of the process and gains traction in various corners of the pharmaceutical sector. Such eminent features of the lab-on-a-chip device are propelling the global lab-on-a-chip device market in exponential ways.

Global Lab-on-a-Chip Device Market: Drivers & Trends

Presently, the lab-on-a-chip device is experiencing immense popularity in diagnosing of various infections and chronic diseases. On this note, the factors that are airing the demand for this lab-on-a-chip are its portability, automated sample handling, and comfortable configuring and the potential to revolutionize the biomedical field. These are also contributing to the lab-on-a-chip device market to expand drastically in medical use across the globe.

Similarly, other factors such as multiple advantages of microfluidic technology, rise in demand for diagnostics, expanding global population with the prediction of significant growth opportunities, and technological advancements in laboratories have amplified the penetration and growth of the lab-on-chips market globally. Also, the use of lab-on-a-chip devices mainly in research purposes is gaining the major traction owing to its easy portability feature, automated biochemical assays, and massive sample handling provision, which is making devices reliable and usable in a very convenient way. Such factors are streaming to take the global lab-on-chips market to new heights at a higher CAGR during the forecasted period.

Market Segmentation

According to reports of MRFR, the global lab-on-a-chip market has been segmented by product, technology, application, and end user.

By the mode of product, the market is segmented into instruments, reagents & consumables, software, and others.

By the mode of technology, the market is segmented into microarrays, microfluidics, tissue biochip, and others.

By the mode of the application, the market is segmented into genomics, proteomics, the point of care diagnostics, drug discovery, and others.

Lastly, accounting on the end-user, the market is segmented as hospitals and clinics, biotechnology and pharmaceutical companies, forensic laboratories, diagnostics centers, and academic & research institutes.

Regional Outlook

On a geographical note, the global lab-on-a-chip device market has covered the main regions of America, Europe, Asia Pacific, and the Middle East & Africa.

Among all, the Americas is the market leader and has an attractive lab-on-a-chip devices market growth owing to mounting advances in molecular biology and genetic engineering techniques as well as increasing prevalence of infectious diseases. Also, factors such as swelling genomic and proteomics research labs, government initiatives and funding for research, development of progressive medical treatment options, and rising demand for portable devices are possible to augment the growing lab-on-a-chip device market in the American region. According to stats by the Centers for Disease Control and Prevention report in the year 2017, around 49.9% of the children between the ages of 6 months to 17 years received an influenza vaccine. Owing to the distressing rate of chronic as well as infectious diseases, use of lab-on-a-chip devices was accelerated in diagnosis and multiple samples handling which catered the best use of it.

Similarly, Europe is also considered as the second largest market and holds a healthy share in the global Lab-on-a-Chip device market owing to main driving factors such as the thriving medical device market, favorable government initiatives to promote clinical research, rising average per capita income. The European Commission also quantified that the research & development by the pharmaceuticals and biotechnology sectors grew by 8.7% in 2014. This investment in R&D, along with the enduring legislative reforms, are predictable to have a constructive impact on the Lab-on-a-Chip device market in the years to come.

While in the Asia-Pacific region, it is expected that this region will be the fastest growing market owing to the more rapid adaptation of healthcare technology, increasing chronic patients and infectious diseases, government initiatives of healthcare reform, a growing number of CROs and research projects on environmental issues. Furthermore, key medical device players have already set up their regional headquarters and manufacturing plants in countries such as China, Japan, and Australia; thus, boosting the growth of Lab-on-a-Chip device market during the forecast period.

Lastly, the Middle East & Africa is also expected to portray the least growth in the market owing to lack of awareness, limited access, and availability of treatment facilities. While, in the Middle East, the United Arab Emirates has the largest market share owing to the development of the healthcare industry and overall economic status in this region.

Key Players

Market Research Future (MRFR) distinguishes the following companies as the key players in the global lab-on-a-chip device market. The names are Becton, Dickinson And Company, Agilent Technologies, Inc., Danaher Corporation, Bio-Rad Laboratories, Abbott Laboratories, F. Hoffmann-La Roche AG, PerkinElmer, Inc., IDEX Corporation, Thermo Fisher Scientific, Inc., Cepheid Inc., and Biacore AB.

OBTAIN RESEARCH REPORT DETAILS WITH TOC @ https://www.marketresearchfuture.com/reports/lab-on-a-chip-device-market-6215

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

Industry Analysis Reports | Health Care | Medical Devices | Pharmaceutical

Labels

Monday 30 November 2020

Global Healthcare Contract Manufacturing Market- Demand, Analysis and Forecast

Latest Research On Diagnostic imaging Market Key Manufactures Shares, Analysis and Forecasts Till 2023

News 2020: Hair transplant Market Size, Trends and Global Demand by 2023

Regional Trends on Smart Insulin Pens Market Size by Top Companies, Share, REport and Demand by 2027

Vocal Biomarkers Market Technology Trends, Demand, Key Trends and Forecast

Report: Cystic Fibrosis (CF) Therapeutics Market 2020 | Size| Trends | Global Report | News

Sunday 29 November 2020

Analysis On Homeopathic Medicine Market -Key Trends and Growth By 2023

NEWS: Aromatherapy Market -global Trends, Demand, Size, Share and Forecast

Analysis On Dental Sterilization Market (2018-2023) | Analysis | Size| share| Demand by Top Companies

News: Lab-on-a-Chip device market | Growth Factors | Demand| Size | Share and Trends

Market Insights

Blog Archive

Total Pageviews